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Abstract 
Our lab previously used the hypoxic mimic compound, DFO, to simulate hypoxic 
conditions within neuronal cells, NMB, model system, and found that treatment decreased cell 
viability in a dose- and time-dependent manner. In the surviving cells there was an observed 
increase of glutathione levels and an increase of hypoxia inducible factor-l a mRNA. Although 
adaptive responses were identified in this cell model, how cells convey the message ofchemical 
compound treatment into the cells is still unknown. Thus, investigation into the potential signal 
transduction pathways was performed in this study using NMB cells treated with DFO and CoCh 
individually to simulate hypoxia. Members of the MAP kinase family, ERK1I2 and JNK, and 
transcription factors, ST ATl and ST AT3, are known to initiate the signaling cascades that 
mediate gene expressions for cell survival in low oxygen conditions and were thus chosen for 
examination in this study. Western blot analysis revealed that DFO treatment increased the 
activity ofSTAT3 and decreased activity for ERKl/2 (Thr 160, Thr 177) and JNK. Additional 
Western blot analysis revealed that CoCh treatment increased activity for ERK1I2 (Thr 160, Thr 
177) and decreased activity of JNK. Results for p-STAT3 revealed an initial increase then a 
decrease in activity after 24 hours. Western blot analysis revealed that, ERK1I2 (Thr 202, Tyr 
204) and STATI had no observable change in activity regardless of which chemical mimicker 
was used. Above data suggested that various signal transductions pathways were altered 
simultaneously in response to the chemical simulated hypoxia in NMB cells. The activities of 
MAP kinase and STAT family fluctuated positively or negatively in response to chemical 
hypoxic mimic compounds implicating that the development of different adaptive responses 
related to DFO and CoCh treatments. 
vi 
Introduction 

Oxygen is one ofmost abundant elements in Earth, and it greatly impacts life ofboth 
prokaryotics and eukaryotics. Life has evolved and adapted to be able to utilize oxygen to fulfill 
many different redox reactions allowing for various cellular functions to be performed. The 
metabolism ofhumans, in particular, utilizes oxygen from the air to extract daily 2550 calories 
(based on a 70 kg 20 yr old male) from food in order to perform necessary metabolic functions 
(Wagner et aI., 2011). 
Oxygen is utilized in various parts ofmammalian cells, most importantly as the fmal 
electron acceptor in the mitochondria's electron transport chain reaction where the vast majority 
ofadenosine tri-phosphate (ATP) energy is generated. Without this massive reservoir ofA TP, 
most cellular tasks necessary for growth and survival could not be completed. Some cells, such 
as human erythrocytes, do not possess organelles such as mitochondria and rely solely on 
glycolysis to generate ATP to fuel cellular functions (Markuszewski et aI., 2005). Thus, any 
change to oxygen levels would not greatly impact the overall production ofATP in these types of 
cells. However, most human cells would be affected by a change in oxygen and would be forced 
to respond to the insult. 
Neuronal cells of the nervous system (for both PNS and eNS) are highly active and 
therefore require large quantities of ATP (Ames, 2000). Thus, neurons are sensitive to the 
fluctuations ofoxygen level and the decrease ofATP production as compared to the other cell 
types. For example, the A TP generated in the mitochondria ofneurons is used to maintain the 
stability of the Na+!K.+ pumps along the cellular membrane in order to maintain the membrane 
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potential (Hansen, 1985). With low oxygen levels, anaerobic metabolic pathways do not generate 
enough energy to sustain this function, resulting in an extra intracellular Na+, and causing 
depolarization of neuronal cells (Won et al., 2002). This depolarization may induce apoptotic 
pathways and leads to cell death. 
When oxygen levels for an organism are lower than the normal concentrations, the 
environment is defined as hypoxic. Although there is no set value in literature for the 
concentration of oxygen to be used as a determining factor for hypoxia, values of 0 to 1% 
oxygen concentration, as compared to an organism's normal oxygen concentration, are widely 
accepted to be in the realm ofhypoxia (Smensen et al., 2009). Hypoxic conditions force cells to 
adapt or initiate apoptosis. Apoptosis initiator molecules include caspases, such as Caspase 9, 
which signals the cell to begin the steps necessary for programmed cell death. Caspase 9 is 
activated when damage occurs to the mitochondria, disrupting A TP generation, and dislodging 
cytochrome C which in turn activates apoptosome that cleaves pro-enzyme caspase 9 to its active 
form (Delivoria-Papadopoulos et al., 2007). This molecule consequently cleaves procaspase 3 
and 7 allowing the active forms of the aforementioned caspases to activate such molecules as 
poly-ADP ribose polymerase (PARP). P ARP actively works on depleting ATP in the cell as well 
as starting the pathway for release of apoptosis inducible factor (AIF) from the mitochondrial 
membrane (Delivoria-Papadopoulos et aI., 2007). 
As seen with the caspase 9, apoptosis may occur due to the dislodging of vital 
fiavoproteins or molecules such as cytochrome C from the mitochondrial membrane, which are 
integral to the production of A TP. Without these components, the electron transport chain fails to 
deliver the passing electron to the final electron acceptor, oxygen. Less A TP generation occurs, 
and the cell lacks the capacity to continue normal cellular functions ultimately leading to 
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programmed cell death. Not all fonus ofstress to a cell or to the mitochondria results in the 
immediate activation of molecules designated to apoptosis such as the aforementioned caspases. 
A mechanism has evolved in mammalian cells that allows for a temporary respite against 
hypoxic stress conditions that could disrupt the mitochondria's integrity. 
Under low oxygen conditions, the hetero-dimeric compound hypoxia inducible 
factor (HIF) is activated, which may lead to promotion of key genes for cell survival (Manolescu 
et al., 2009). HIF is a transcription factor, and is composed oftwo subunits, HIF-l alpha, an 
oxygen sensitive factor, and HIF-I beta, which is oxygen independent protein (Rahman and 
Thomas, 2007). HIF-1 alpha may be referred to as an oxygen sensor for a mammalian cell, 
although this molecule does not directly interact with the oxygen molecule. HIF-I alpha is 
regulated by prolyly hydroxylases (PHDs) that utilize oxygen, iron, and ascrobate as cofactors 
(Millonig et al., 2009). When oxygen levels are normal, PHD hydroxylation penuits binding of 
von Hippel-Lindau tumor suppressor protein (pVHL) to HIF-l alpha thus beginning 
polyubiquitination of HIF-1 alpha, targeting the subunit for proteasomal degradation (Millonig et 
al., 2009). However, during hypoxia, PHD activity decreases in correlation to the reduce levels 
of oxygen. Thus, degradation ofHIF-I alpha is decreased, resulting in the accumulation of the 
alpha portion ofHIF. HIF-1 alpha is then able to translocate to the nucleus and heterodimerize 
with HIF-I beta which promotes the transcription ofHIF regulated genes (Millonig et al" 2009). 
These known genes may be grouped by function that includes the following: increase of 
anerobic metabolism (Le., glyceraldehydes-3-phosphate dehydrogenase), vascular regulation 
(Le., vascular endothelial growth factor (VEGF)), and erythropoiesis (Le., erythropoietin) 
(Komatsu and Hadjiargyrou, 2003). The products of these genes allow for the cell to operate and 
maintain homeostasis under the adverse low oxygen conditions. 
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The signal transduction pathway that allows for the stabilization ofHIF-1 alpha and 
consequently the promotion of expression of survival genes during hypoxic events is still being 
explored in many cell lines. However, a constant component of the identification of potential 
pathways that allow for the adaption to stress, such as low oxygen, is likely related to the activity 
ofkinases (Nakabayashi and Sasaki, 2004), which are responsible for conveying a signal in the 
form of a phosphate group and leading to the eventual activation or inhibition ofthe targeted 
genes related to the initial signal (Nakabayashi and Sasaki, 2004). Kinases are categorized by 
similar chemical structures and response to similar stimuli. In the literatures, a variety of kinases 
within a myriad of signal transduction pathways are associated with responding to low oxygen 
environments (Yang et al., 2005). 
In particular, the family of mitogen activated proteins (MAP) has been reported to be 
active under hypoxic conditions, and the MAP kinase family may be responsible for cell 
adaptation and survival under unfavorable conditions (Yang et al., 2005). Currently, three 
kinases, extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38 
group ofprotein kinases are known to belong to the MAP kinase family (Zarubin and Han, 
2005). ERKs have been reported to regulate and respond to growth factors and monitor cellular 
division as witnessed by observation of concentrations ofVEGF in primary cortical neurons 
under adverse conditions (Ma et aI., 2011). In regards to low oxygen environments, an increase 
ofactivity of ERK1I2 was found in human microvascular endothelial cells-l (HMEC-l) (Minet et 
al., 2000). JNK is a stress kinase that functions primarily with mitigating responses to external 
stimuli such as cytokines and heat shock (Weston and Davis, 2002), but has also displayed 
activity in hypoxic environments. For example, an increase of JNK activity in a hypoxia 
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environment, such as a hypoxic gas chamber, has also been found in cerebral cortical neuronal 
nuclei ofnewbom piglets (Mishra et al., 2004) 
Similarly, Signal Transducer and Activator of Transcription (STAT) may also be 
activated either by stress or cytokine stimulation (Takeda and Akira, 2000; Horvath, 2000). Up 
to now, seven STAT proteins are identified in mammals: STATI, STAT2, STAT3, STAT4, 
STAT5, STAT6, and STA T7 (Lee et al., 2006). All STATs have conserved domains, including a 
SH2 domain near the carboxy-terminus, and located here is a tyrosine residue that is the target of 
phosphorylation by such molecules as Janus kinase (JAK) (Takeda and Akira, 2000). Once 
phosphorylated ST A Ts either homo- or hetero-dimerize through interactions ofone STAT to 
another's SH2 domain, allowing for translocation into the nucleus to alter the targeted gene 
expressions (Takeda and Akira, 2000). Several known STAT target genes have been identified, 
and these genes are involved in embryonic development, programmed cell death, organogenesis, 
innate immunity, adaptive immunity, and/or cellular growth (Horvath, 2000). Previously, 
increases of ST A TI and STAT3 activities under hypoxic conditions have been reported using 
human breast cancer cell line (MCF-7) (Lee et al., 2006). 
The potential involvement of the MAP kinase subfamily and STATs in response to low 
oxygen environments in human neuronal cells (neuroblastoma, NMB) was therefore examined. 
The chemical mimickers, cobalt chloride (CoCh) and desferrioxamine (DFO) were used to 
simulate hypoxia. Previously, our lab reported that when administering DFO in a dose and time 
dependent manner, there was an increase in levels ofglutathione and higher concentrations of 
HIF (Cook et al., 2010). HIF is a strong promoter in mammalian's adaptation to low oxygen 
insults. Glutathione is responsible for negating damaging free radicals and preserving and 
regulating DNA synthesis. Using confocal analysis with annexin-V-fluorescein and propidium 
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iodide staining revealed that surviving/attached cells under DFO challenge were morphologically 
similar to control (vehicle-treated) cells (Cook et al, 20 I0). Thus, this cell model system permits 
investigation into potential pathways that allow for adaptation ofNMB cells to hypoxic 
rnirnickers. 
Two hypoxic mimics, DFO and CoCh, were chosen for this study. Either chemical is 
able to produce a mimic hypoxic condition in cells by acting as an iron chelator that affects the 
binding of the hydroxyl group to HIFl-alpha by PHD (Semenza, 2004). The structure of PHD 
contains an Fe(++) at its catalytic site, and unlike a red blood cell's heme group, PHD's iron 
component may be easily chelated out ofthe molecule (Semenza, 2004). With the removal ofthe 
iron by either DFO or CoCh, PHD is no longer stable and is unable to hydroxylize HIF I-alpha, 
thus the signal for pVHL to add an ubiquitone to HIFl-alpha is stopped. Although DFO chelates 
the iron component through a hydroxamic group (R-CO-NH-OH) (Harmatz et al., 2007) and 
CoCh binds the iron molecule via the strong negative charge of cobalt, the end result is the same. 
PHD is destabilized and HIF-l alpha is not targeted for proteasome degradation; instead, HIF-l 
alpha concentration accumulates and translocates to the nucleus to dimerize with the HIF-l beta. 
Therefore, the objective of this thesis is to investigate prospective adaptive signal 
transduction pathways ofNMB cells in response to hypoxic stress simulated by chemical 
mimickers, DFO and CoCh. The potential kinases and transcription factors, ERK112, JNK., 
STATt, and STAT3, were examined in response to either DFO or CoCh in this study. 
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Material and Methods 

Cell Culture: 
Human neuroblastoma (NMB) cells were grown in Roswell Park Memorial Institute Medium 
(RPMI) with the addition of 10% Fetal Bovine Serum at 37 degrees Celsius and 5% CO2 
incubator. Cells were treated with either a single dose of O.3mM desferrioxamine (DFO) or 
O.3mM cobalt chloride (CoCh) and were incubated for various times as indicated in the results. 
Both DFO and CoCh were obtained from Sigma-Aldrich (St. Louis, MO). 
Cell Lysis: 
NMB cells were harvested by removal ofmedia, washed with cold PBS, and disassociated from 
the flask using PBS-EDTA. The cells were then lysed by adding lysing buffer containing 1% 
SDS, PBS, and the following protease inhibitors with a uniform concentration of 1.0 mM: 
sodium orthovandate (Na3V04), pepstatin, aprotinin, phenylmethylsulphonyl fluoride (PMSF). 
The cell mixture was then sonicated. The resulting lysates were stored at ·80 degrees celsius. 
Lowry Assay: 
Protein concentration ofcell lysate was determined by a Lowry Assay (Lowry et aI., 1951). 
Bovine serum albumin (BSA) was used to as the protein standard for generating the standard 
curve. Briefly, protein samples were incubated with solution C (1.8mM Na2Co3, 98mM NaOH, 
0.95mM sodium potassium tartrate, and 0.4mM CUS04 5H20) at room temperature for 10 
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minutes, and then further incubated with Folin-Ciocalteau reagent (Lowry et aI., 1951). Protein 
concentration was determined using spectrophometer at 660 run. 
Western Blotting: 
Sample protiens were first separated using a lO% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-P AGE). The gel was then electically transferred onto 
phenylmethylsulfonyl fluoride (PVDF) membranes from GE Healthcare. The membrane was 
then blocked using blocking solution, containing a mixture of evaporated milk and 0.3% Tween 
Twenty-Buffer Solution, probed with JNK, ERKl/2 primary antibodies from Santa Cruz Bio­
Technology (Santa Cruz, CA) and STATl and STAT 3 primary antibodies from Cell Signalling 
Technology (Danvers, M.A.), and subsequently probed with secondary antibodies from Jackson 
Immuno Research (West Grove, PA). The signals were detected with chemiluminescence 
detection system (Amersham Biosciences, Piscataway, NJ). 
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Results 

Previously, the human neuronal hypoxic model was generated by treating human 
neuroblastoma, NMB, cells with the hypoxic chemical mimicker DFO (Cook et ai, 2010). An 
increase, as depicted in a concentration and time dependent manner, ofHIF and cellular 
glutathione levels were found in surviving cells under such a treatment (Cook et ai, 2010). 
Although the increase of both HIF and glutathione levels has been reported in this cell model, the 
pathways that convey activation and/or may pertain to the increase of these two critical 
components were not identified. Thus, to investigate the potential signal transduction pathways 
that respond to such a hypoxia simulated condition in the cell model system, the chemical 
hypoxic mimickers, DFO and CoCh, were used and the obtained results were compared in this 
study. 
Several key enzymes are known to be involved in the potential signal transduction 
pathways (Lee et aI., 2006; Wang et aI., 2005; Minet et aI., 2000; Chen et aI., 2010; Tanga et aI., 
2009; Yang et aI., 2005; Vacotto et aI., 2008). For example, the activities of members ofMAP 
kinase subfamily, extracellular signal-regulated kinase (ERK1I2) and c-jun N-terminal kinase 
(JNK) and signal transducer proteins such as Signal Transducer and Activator ofTranscription 1 
(ST AT1) and Signal Transducer and Activator of Transcription (STAT3) were shown to be 
changed under a low oxygen environment. Most often this type of signal resided in the form of a 
phosphorylated kinase/protein; thereby, the analysis of the altered level/amount of 
phosphorylated proteins will allow examination of changes in their active status. In addition, the 
fluctuations of phosphorylation levels of a protein were mostly observed in a short time period 
(Lee et aI., 2006; Wang et aI., 2005; Minet et aI., 2000; Chen et aI., 2010; Vacotto et aI., 2008). 
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Therefore, in this study, neuronal cells, NMB, were exposed to 0.3 mM ofDFO or 0.3 mM of 
CoCh for a short period of time, 5 minute (min), 10 min, 15 min, as well as for a longer time 
period, such asl hour (hr), and 24 hr. The protein kinases' activities were then monitored by 
observing changes in their phosphorylation levels detected by Western Blot analysis that utilized 
specific phosphorylated antibodies to probe for the corresponding investigated protein kinase. 
Investigation of p-ERKI12 activity using neuronal cells treated with DFO 
Measurement ofERK1I2 activity was achieved through Western blot analysis using 
p-ERKII2 (Thr 160, Thr 177) antibody. Beta tubulin is a cytoskeleton house-keeping protein and 
consequently its signal was utilized as an internal standard for nonnalization. 
Western blot analysis (Fig. lA) showed that activity of p-ERKII2 (Thr 160, Thr 177) 
decreased from 5 min to 1 hr. Quantitative data was shown in Fig. IB, revealing that the decrease 
ofactivity is significantly observed at 1 hr treatment (p <0.005). Upon the 24 hr treatment, the 
activity ofp-ERK1I2 (Thr 160, Thr 177) resumed to nonnallevel. These results suggested that 
DFO causes a decrease in p-ERK1I2 (Thr 160, Thr 177) activity with the 1 hr time point 
displaying a significant reduction. 
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C 5 10 15 lhr 24hr 
A ~-~-~ P-ERK1/2 
Beta-Tubulin 
p·ERK1/2 Activity towards DFO 
1<10B 
Hl) 
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Control 5mln 10mln lSmln 1 hour 24hoUf 
Figure 1. ERK1I2(11u 160. TIll' 177) activity inhumanneul'onal cells exposed to DFO at varionstimepoints. Cells 
were treated fOl' 5 min.l0 min.15 min. 1 hr. and 14 hr. and p-ERKlll was examined llsillg Westem bJot analysis. 
(A) Represelltativewestern blot image ofp-ERKl/1 011 top. with Beta-TIlbulin on bottom. (B) Quantification ofp­
ERKlIl(1111' 160.TIl1'177) normalized to Beta-TI.bldill. Vailles are representative ofthe means with +1· SE. N=6. * 
hldicates the significant change with a p-vaille less t1UIll 0.0.:". 
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Investigation ofp-ERKl/2 activity in the cells treated with CoCh 
Similarly', Western blot analysis was performed using p-ERKII2 (Thr 160, Thr 177) 
antibody with the same cell line. The cells were treated with CoCh for 5 min, 10 min, 15 min, 1 
hr, and 24 hr. Beta tubulin is utilized as an internal standard for normalization. 
Western blot analysis (Fig. 2A) demonstrated that activity of p-ERK1I2 
(Thr 160, Thr 177) showed no significant decrease within 15 min exposure to CoCh. However, 
there was a noted increase of p-ERK112 (Thr 160, Thr 177) activity after 1 hr and 24 hr ofCoCh 
simulated hypoxia. Quantitative data was shown in Fig. 2B revealing that the increase of activity 
at 1 hr is significantly observed (p < 0.05). These results suggested that CoCh causes an increase 
of activity ofERK1I2 (Thr160, Thr 177) at the 1 hr and 24 hr treatment. 
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Figure 2. ERKlll(11u 160. TIu'l ii) activity in neuronal cells exposed to CoCl2at variolls time points. Cells 
were treated for ~ min, 1 0 min.15 mill, 1 hr. and 24 hr, and p-ERKl/2 was examined using Western blot 
analysis. (A) Representativewestelll blot image ofp-ERKlf2 on top. with Beta-1\lbulin on bottolll. (B) 
Quantification ofp-ERKlf2(11u·160. TIul 77) norlllalizedto Beta-1\lbulin. Values arerepreselltativeofthe 
means with +1- SE. N=6. * Indicates tbe sigllificant cballgewith a p-valueless thalJ 0.05. 
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Investigation ofp-ERK1I2 activity in cells treated with DFO and CoCh 
Measurement ofERK1I2 activity was achieved through Western blot analysis using 
p-ERK1I2(Thr 202, Tyr 204) antibody, and beta tubulin was utilized as an internal standard. 
Western blot analysis (Fig. 3) revealed that there was no detectable activity ofp-ERK1I2 
(Thr 202, Tyr 204) regardless of which chemical mimicker was used, DFO or CoCh. These 
results showed that the activity ofERK1I2 (Thr 202. Tyr 204) was not altered in the presence of 
any of the chemical treatments. 
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DFO 
c 10 15 1hr 24hr c 5 10 15 1hr 24hr 
P-ERKII2 

(Thr 202. Tyr 204) 

Beta-Tubulill 
Figure 3.1ime course of ERK 112(thr 202, tyr 204) activity in celb exposed to DFO or CoCI;/. Cells were treated in one dose at 
10min, 15 min, 1 hr. and 24 hr and p-ERK 112 was examined by Western blot. Representative western blot image of p-ERK 112 
(thr202. tyr 204) on top. with Beta-Thbulin on bottom. N=4 for both DFO and CoC12trialS. Little observed activity ofp-
ERK 112 (thr 202, tyr 204) regardless if DFO or COCI2 was used to simulate hypoxia in neuronal cells. 
15 

Investigation of p-JNK activity using cells treated with DFO 
Measuremen! of JNK activity was achieved through Western blot analysis using p-lNK. 
antibody and beta tubulin as an internal standard. 
Western blot analysis (Fig. 4A) revealed that activity of p-JNK decreased from 5 min to 
15 min. Quantitative data was shown in Fig. 4B revealing that the decrease of activity is 
significantly observed at 5, 10, and 15 min. treatments (p< 0.05). Activity ofp-JNK began to 
gradually resume to normal level after 1 hr and 24 hr exposure. These results showed that DFO 
treatment caused the decrease of JNK activity starting at the first 15 min and then gradually 
returned to normal levels starting at Ihr. No significant difference was found at the 24 hr 
treatment. 
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Figure4. nme cOlUseofJNK activity ill cells exposed to DFO. Cellswerebeated for;'l min, 10 min, 1:'1 min, 1 
hr. an<l24 hr. andp-JNK wasexaminedusingWeslem blot analysis. (A) Representativewestem blotimageofp­
JNK on top. with Beta·nlbulin on bottom. (B) Quantification ofp-JNKnormalized to beta·nJbulin. Values are 
representativeofthemeans with +1- SE. N=6. * Indicates thesignificanl change with a p-valueless than 0.05. ~,* 
Indicatesp·valueless than 0 .005. 
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Investigation of p-JNK activity using cells treated with CoCh 
Similarly~ Western blot analysis was perfonned using p-JNK antibody with cells treated 
with CoCh for 5 min, 10 min, 15 min, 1 hr, and 24 hr. Beta tubulin was again utilized as an 
internal standard. 
Western blot analysis (Fig. 5A) revealed that activity of p-JNK decreases from 5 min 
through 24 hr. Quantitative data was shown in Fig. 5B revealing that the decrease of activity is 
significantly observed at 10 min, 1 hr, and 24 hr. treatment (p < 0.05). This data showed that 
CoCh treatment caused a continual decrease of activity of JNK starting at 5 min. 
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FigureS.lime course ofJ'Nk Ilctivltyincelts exposed to coa2.Cells were treated fod min, f6 min. ·15 min, 

1hr. and 24 hr. and p...mK was examined using Western blot analysis. (A) Representative western blot image of 
p.JNK on top. with beta-Tubulin on bottom. (B) Quantification of p-JNK normalized to beta-1bbulin. Values 
are representative of the meanS with +/. SE. N=6. * Indicates the significant change with a p-value less than 
0.05. ** Indicates p-value less than 0.005. 
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Investigation of p-ST A T3 activity using cells treated with DFO 
Measurement ofSTAT3 activity was achieved through Western blot analysis using 
p-STAT3 antibody. Beta tubulin is a cytoskeleton house-keeping protein and consequently was 
utilized as an internal standard. 
Western blot analysis (Fig. 6A) revealed that activity of p-STAT3 increases slightly from 
5 min and to the 24 hr treatment. Quantitative data was shown in Fig. 6B revealing that the 
increase of activity was significantly observed at 5 min and 15 min (p< 0.05), and at 24 hr 
treatment (p<0.00 1). These results showed that an increase of STAT3 activity of is significantly 
observed at 24 hr treatment. 
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C 5 10 15 1hr 24hr 

A P-STAT3 
Beta-Tubulin 

p-STAT3 Activity towards DFOB 
Control Smin 10 min 15min lhoUf 24h<>ur 
Figure 6. Time course of STATI activity in cells exposed to DFO. Cells were treated for 5 min. 10 min. 15 
min, 1 hr. and 24 hr. and p-STATI was examined using Western blot analysis. (A) Representative western 
blot image ofp-STAT3 on top, with beta-Thbulin on bottom. (B) Quantification ofp-STATI normalized to 
beta-Thbulin. Values are representative of the means with +/. $E. N=6. * Indicates the significant change 
with a p-value less than 0.05. ** Indicates p-value less than 0.005. 
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Further investigation of p-STAT3 activity using cells treated with DFO 
Measurement ofSTAT3 activity was further investigated using 4 hr, 6 hr, 8 hr, 12 hr, and 
24 hr treatment by Western blot analysis using p-STATI antibody and beta tubulin was again 
utilized as an internal standard. 
Western blot analysis (Fig. 7A) revealed that activity ofp-STAT3 increases at 12 hr and 
24 hr. Quantitative data was shown in Fig. 7B revealing that the increase of activity is 
significantly observed at both 12 hr and 24 hr treatment (p < 0.005). These results indicated that 
DFO causes a significant increase ofactivity at the 12 hr and 24 hr time intervals. 
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Figure 7. TIme course of STAT3 activity in human neuronal cells exposed to CoCI2< Cells were treated 
for 4 hr, 6 hr, 8 hr, 12 hr. and 24 hr • and p-STAT3 was examined using Western blot analysis. (A) 
Representative western blot image of p-STAT3 on top, with beta-Tubulin on bottom. (B) 
Quantification ofp-STAT3 normalized to beta-Thbulin. Values are representative of the means with +1­
SE. N=6 * Indicates the significant change with a p-value less than 0.05. ** Indicates p-value less than 
0.005. 
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Investigation ofp-ST A T3 activity using cells treated with CoCh 
Similarly, Western blot analysis was performed using p-STAT3 antibody with the cells 
treated with CoCh for 5 min, 10 min, 15 min, 1 hr, and 24 hr. Beta tubulin was utilized as an 
internal standard for normalization. 
I 
j 
Western blot analysis (Fig. 8A) revealed that activity ofp-STAT3 increased from 5 min 
i to 1 hr, and decreased at 24 hr treatment. Quantitative data was shown in Fig. 8B revealing that 
i 
1 the increase of activity was significantly observed at the 1 hr treatment (p < 0.005) and a 1 
I decrease ofactivity was significantly observed at 24 hr treatment (p < 0.001). Thus, the data ! 
i 
i showed that when CoCh caused an increase of activity ofSTAT3 up to 1 hr, whereas there was a 
.1 
~l 
i drastic decrease of activity observed at the 24 hr treatment.I 
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Fi,ure 8. 'Ilme course of STAT3 activity in cells exposed to DFO. Cells were treated for 5 min. 10 min, 
15 min, 1 hr, and 24 hours, and p-STAT3 was examined usin, Western blot analysis. (A) Representative 
western blot image ofp-STAT3 on top, with Beta-Thbulin on bottom. (B) Quantification ofp-STATI 
norma1i~ed to Beta-Thbulin. Values are representative of the means with +1- SE. N=6, * Indicates the 
sipficant chanae with a p-value less than 0.05. ** Indicates p-value less than 0,005. 
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Investigation of p-ST AT 1 activity using cells treated with DFO and CoCh 
Measurement of STATl activity was achieved through Western blot analysis using p­
STATl antibody and beta tubulin was utilized as an internal standard. Western blot analysis 
(Fig. 9) revealed that activity ofp-STATl was not detectable regardless of which chemical 
mimicker was used, DFO or CoCh. These results showed that the activity ofSTATl was not 
altered in the presence of either of the chemical treatments. 
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Figure 9 . TIme course of STATl activity ill cells exposed to DFO or CoCI2. Cells were treated for 
~1llin.l0 Jllin.l~ mill.l hr. and 24 hr. andp·STATl was examined using Western blot analysis. 
Representative west em blot image ofp-STATI on top. with beta·1\lbulin 011 bottom. N=4 for both 
DFO and CoCll trials. Little observed activity ofp-STATlregar<lessifDFO 01' CoCI2 was used to 
silnulate hypoxi a ill cells. 
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Discussion 
Previously, a cell model system was used which exhibited several adaptive responses 
upon DFO treatment (Cook et aI., 2010). However, the signaI pathways that may be related to the 
adaptive responses in this cell model system were still unknown. This research was to identify 
signal transduction pathways in response to simulated hypoxia by chemical mimickers, DFO and 
CoCh, by examining the activity changes in MAP kinase subfamily via ERKl/2 and JNK as well 
as transcription factors STATI and STAT3. 
In this study, CoCh treatment caused the activity ofERK1I2 (Thr 160, Thr 177) to 
increase at the treatments of 1 hr and 24 hr (Fig. 2). This increase ofERK1/2 (Thr160, Thr 177) 
activity witnessed in CoCh treatments concurs with other findings ofp-ERK112 
(Thr 160, Thr 177) in human microvascular endothelial cells-l (HMEC-l) cells 
(Minet et. al., 2000), human placental artery endothelial (HPAE) cells (Wang et al., 2009), and in 
primary cultured SD rat corticaI neurons (Tanga et aI., 2009), all of which used gas chambers to 
create a low oxygen environment. In HMEC-l cells the increase of activity of the monitored 
kinase was observed at 30 min, Ihr, and 2 hr ofhypoxic exposure (Minet et. aI., 2000) and 
primary cortical neurons showed an increase of kinase activity after 90 min (Tanga et al., 2009); 
however, in HPAE cells the increase of activity ofERK1I2 (ThrI60, Thr177) was noted at an 
early 5 min time point (Wang et aI., 2009). On the other hand, DFO treatment revealed that there 
is a decrease ofERK1I2 (Thr 160, Thr 177) activity between 5 min to 1 hr as seen in Figure 1, 
and activity resumed to normal levels after 24 hr exposure. In human monocytic leukemia THP-l 
cells, D FO resulted in an increase ofp-ERK112 from 1 hr to 12 hr then a decrease to nonnal 
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levels after 24 hr (Soo et al., 2006). Different responses were observed which may be a result of 
different cell types as well as different treatments. 
There was no significant ERK1I2 (Thr 202, Tyr 204) activity detected (Fig 3) under 
either DFO or CoCh treatment. This observation corroborates with the report ofp-ERK1I2 
(Thr 202, Tyr 204) in rat neural stem cells undergoing 0.3% oxygen levels (Chen et al. 2010). 
However, in human HMEC-l (Minet et al., 2000) an increase of activity of ERK1/2 
(Thr 202, Tyr 204) from 30 min to 2 hr was reported, which may be due to the different 
responses of cell types. 
Although ERK1/2 is comprised ofERKl and ERK2 which share a 90% identical a.a. 
sequence to one another (Kinoshita et al., 2008), there was observed in this study a stark contrast 
in presence and activity of ERK1I2(Thr 160, Thr 170) and ERK1I2 (Thr 202, Tyr 204). 
Literature has shown that ERK1/2 needs to be phosphorylated at two sites, either Thr 202, Tyr 
204 or Thr 185, Tyr 187 to achieve full catalytic function (Kinoshita et al., 2008). 
MAPkinaselERK kinase (MEK) in the well studied RAS, RAP, and MEK signal transduction 
pathway, can dual phosphorylate ERK1/2 at either of the aforementioned two sites (Ramos, 
2008). However, there exists on ERK 112 other phosphorylation sites in a Fegion of amino acid 
residues within the same Thr-Glu-Tyr motif that contains Thr 202, Tyr 204 and Thr 185, Tyr 187 
(Wortzel and Seger, 2011). The phosphorylation ofthese nearby amino acid sites may be vital 
for signal transduction pathways involving ERK1I2. For example, ERK1I2 mutations in the sites 
ofThr 173-178 revealed that these residues are important for sub-cellular localization ofERK1I2 
as well as promoting other regions of ERK for overall catalytic function of ERK1I2 (Bendetz­
Nezer and Seger, 2007). Thus, differences observed between the two ERK1I2 sets in this study 
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may be the result of signal transduction phosphate binding preferences on ERK 1/2 within NMB 
cells. 
In addition, DFO treatment revealed that there is a decrease in JNK activity between 5 
min to 15 min (Figure 4), and activity began to increase at 1 hr and return to normal levels after 
24 hr exposure. CoCh treatment revealed there is also a decrease in JNK activity starting from 5 
min to 24 hr (Figure 5). As compared to the other reports, rat neural stem (Chen et al. 2010) cells 
showed an increase ofp-JNK signal at 6 hr, 12 hr, and 24 hr at 0.3% oxygen level, and 
observation ofcerebral cortical neuronal nuclei of newborn piglets (Mishra et al., 2004) which 
had undergone gas chamber hypoxia, displayed an increase of JNK activity after 1 hr exposure. 
Also, avian TUNEL-positive pyknotic cells (Vacotto et al., 2008) showed an increase of INK 
activity after 10 and 30 min at 0.3% oxygen level. In some cell lines the role ofJNK may be 
associated with the preservation of the cell through strong cellular survival signal transduction 
pathways, which would lead to an increase of p-JNK. However, there is a possibility in human 
neuronal cells to be more inclined to apoptosis signaling through JNK than cell survival 
signaling under stress conditions. Thus, if the neuronal cells are trying to survive an oxygen 
insult, then suppressing p-JNK apoptosis signal transduction pathway would allow a higher 
chance of cell survival. Therefore, such a difference between results seen here and literature 
may be due to the different species used andlor under different hypoxic environments. 
There was no significant activity ofp-STATI detected in this study (Fig. 9) under either 
DFO or CoCh treatment. However, in different cell lines such as mouse mammary epithelial 
cel1s( HCII) and human breast cancer cell line (MCF-7) (Lee et al., 2006), and human 
pulmonary arterial smooth muscle cells (pASMC) (Wang et al., 2005) there was an increase of 
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p-STATI reported. Although no significant change ofSTAT 1 activity using human neuronal 
cells was found in this study, there was the increase ofSTAT3 activities detected. 
DFO treatment increased STAT3 activity from 5 min to 24 hr (Figure 6), with significant 
increases at 12 and 24 hr in Figure 7. CoCh treatment also showed an increase of STAT3 activity 
between 5 min to 1 hr, but then a sharp decrease after 24 hr (Figure 8). Thus, both DFO and 
CoCh treatments resulted in an increase ofSTAT3 activity with a different timetable. The 
increase activity ofp-STAT3 was observed after 2 to 6 hr of hypoxia by gas chamber and DFO 
in HCll and MCF-7 cells (Lee et al., 2006). Human ovarian cell line A2780 (Selvendiran et al., 
2009) showed an increase of STAT3 activity after 24 hr and 48 hr of hypoxic gas chamber 
exposure, and PASMC cells displayed higher levels ofp-STAT3 after 8 hr exposure to a hypoxic 
I gas chamber (Wang et al., 2005). The consensus would indicate that across multiple species and 
I cell types STAT3 plays an important role in response to hypoxic conditions, regardless of which 
I hypoxic media is used.1 ] 
1 Finally, DFO and CoCh are chemical hypoxic mimickers and thereby the simulated 
I 	 hypoxia environment is not the same as a hypoxic gas chamber. Both DFO and CoCh chelate 
iron from PHD (Semenza, 2004), but in addition, CoCh can also bind directly to pVHL 
I 
l 	 preventing its activity (Yuan et al., 2003). Also worth mentioning, is that 0.2-0.8mM of CoChj 
has been shown in primary cultured mouse astrocytes to be toxic (Karovic et al., 2007). CoCh 1 
1 	 used in this research with a concentration of 0.3mM falls within this parameter ofCoCh toxicity. 
These discrepancies can provide at least a partial explanation as to why there are divergent 
results in the literature, in addition to various species and cell types, which may respond 
I 
1 
J differently in the same condition.i 
I 
!j 
:J 
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Conclusion 
In summary, the objective was to investigate potential signal transduction pathways 
within NMB cells that convey the message from the outside to inside the cells. Members of the 
MAP kinase subfamily as well as the transcription factor order of STATs were chosen for 
examination in this study based on literature revealing the fluctuations of activities under 
hypoxic conditions (Chen et al., 201 0; Lee et aI., 2006; Minet et aI., 2000; Mishra et al., 2004; 
Selvendiran et al., 2009; Tanga et al., 2009; Vacotto et al, 2009; Wang et al, 2005; Wang et al., 
2009). Induction ofhypoxia was performed with the chemical mimickers DFO and CoCh. 
Although both DFO and CoCh have been shown to cause apoptosis in many cell lines, 
(Guo et aI., 2006) they also induce hypoxic mechanisms by chelating iron from PHD allowing 
HIF·I alpha to stabilize and promote adaption to low oxygen signaling. 
Administration of DFO and CoCh to NMB cells revealed fluctuations in activity in the 
target proteins of interest. Western blot analysis ofDFO treatments using specific 
phosphorylated antibodies to the corresponding protein revealed increase in activity ofSTAT3 
and decrease activity of ERK112 (Thr 160, Thr 170) and JNK. Further western blot analysis of 
CoCh treatments revealed an increase ofactivity ofERK1I2 (Thr 160, Thr 170), and a decrease 
ofactivity in JNK. Results for p-ST A T3 revealed an initial increase then a decrease in activity 
after 24 hours. Lastly, Western blot analysis ofERKll2 (Thr 202, Tyr 204) and STATl revealed 
no observable change in activity regardless ofwhich chemical mimicker was applied. 
As observed, there were variations between DFO and CoCh treatments. These may be 
due to the natures of the two compounds. As previously stated, DFO chelates the iron component 
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of PHD, which allows HIF-I alpha to remain stable and begin a hypoxic signal transduction 
pathway. CoCh may chelate the iron component of PHD, but CoCh may also bind directly to the 
VHL (Yuan et aI., 2003). Thus, CoCh prevents VHL from binding HIF-I alpha, allowing this 
molecule to remain stable in a different mechanism than DFO induced hypoxia. Finally, the 
concentration of CoCh used in this research is suggested by literature to have possible cobalt 
toxicity to the treated cells (Karovic et ai., 2007); therefore, the potential adverse effects ofDFO 
and CoCh should be investigated in the future. 
33 

I 

1 
J 
References 

Adamski 1.K., Estlin E.1., Makin G.W.1. (2008). The cellular adaptations to hypoxia as novel 
therapeutic targets in childhood cancer. Cancer Treatment Reviews. 34:231-246. 
Ames III A. (2000). CNS energy metabolism as related to function. Brain Research Reviews. 
34:42-68 
Hansen, A.1., (1985). Effect of anoxia on ion distribution in the brain. Physiological Review. 
65(1):101-48. 
Chen X., Tian Y., Yao L.~ Zhang J., and Liu Y. (2010). Hypoxia stimulates proliferation ofrat 
neural stem cells with influence on the expression ofcyclin D 1 and c-Jun N-Terminal protein 
kinase signaling pathway IN VITRO, Neuroscience. 165:705-714. 
Cook R. 1., Karch C., Nahar P., Rivera A., Ko J. L. (2010). Effects of desferoxamine-induced 
hypoxia on neuronal human mu-opioid receptor gene expression. Biochemical and Biophysical 
Research Communications. 398:56-61. 
Guo G., Song L. P., Jiang Y., Liu W., Yu Y. and Chen G. Q. (2006). Hypoxia-mimetic agents 
desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different 
hypoxia-inducible factor-Io independent mechanisms. Apoptosis. 11: 67-77 
Harmatz P., Grady R. W., Dragsten P., Vichinsky E., Giardina P., Madden J., Jeng M., Miller B., 
Hanson G., and Hedlund B. (2007). Phase Ib clinical trial of starch-conjugated 
deferoxamine(40SD02): a novel long-acting iron chelator. British Journal of 
Haematology.138:374-381. 
Horvath C. M. (2000) STAT proteins and transcriptional responses to extracellular signals. 
Trends in Biochemical Sciences. 25(10):496-502. 
Komatsu D.E., Hadjiargyrou M. (2003) Activation of the transcription factor HIF-I and its target 
genes, VEGF, HO-l, iNOS, during fracture repair. Bone. 34:680- 688. 
Karovic 0., Tonazzini I., Rebola N., Edstro"m E., Lo"vdahl C., Fredholm B.B., Dare E. (2007). 
Toxic effects ofcobalt in primary cultures of mouse astrocytes similarities with hypoxia and role 
of HIF-lalpha. Biochemical pharmacology. 73 :694-708. 
Kinoshita T., Yoshida I., Nakae S., Okita K., Gouda M., Matsubara M., Yokota K., Ishiguro H" Tada 
T. (2008). Crystal structure of human mono-phosphorylated ERKI at Tyr204. Biochemical and 

Biophysical Research Communications. 377: 1123-1127. 

Lee M. Y., Joung Y. H., Lim E. J., Park J. H., Ye S. K., Park T., Zhang Z, Park D. K., Lee K. 1., 

Yang Y. M. (2006). Phosphorylation and activation of STAT proteins by hypoxia in breast 

cancer cells. The Breast. 15(2):187-195. 

34 

Lowry O. H., Rosebrough J. N., Farr A. L., Randall 1. R. (1951). Protein measurement with the 
folin phenol reagent. The Journal ofBiological Chemistry. 193:265-275. 
Ma Y., Liu W., Wang Y., Chao X., Qu Y., Wang K., Fei Z. (2011). VEGF protects rat cortical 
neurons from mechanical trauma injury induced apoptosis via the MEKIERK pathway. Brain 
Research Bulletin. 86:441-446. 
Manolescu B., Oprea E., Busu C., Cercasov C. (2009). Natural compounds and the hypoxia­
inducible factor (HIF) signaling pathway. Biochimie. 91 :1347-1358. 
Markuszewski M. 1., Szczykowska M., Siluk D., Kaliszan R. (2005). Human red blood cells 
targeted metabolome analysis of glycolysis cycle metabolites by capillary electrophoresis using 
an indirect photometric detection method. Journal ofPharmaceutical and Biomedical Analysis. 
39: 636-642. 
Millonig G., HegedUsch S., Becker L., Seitz H.K., 

Schuppan D., Mueller S. (2009). Hypoxia-inducible factor In under rapid enzymatic hypoxia: 

Cells sense decrements of oxygen but not hypoxia per se. Free Radical Biology & Medicine. 

46:182-191. 

Minet E., Arnould T., Michel G., Roland 1., Mottet D., Raes M., Remacle J., Michiels C. 

(2000). ERK activation upon hypoxia: involvement in HIF-l activation. FEBS Letters. 468:53­
58. 
Mishra O. P., Zubrow A. B., and AshrafQ. M. (2004). Nitric Oxide-Mediated activation of 
Extracellular Signal-Regulated Kinase (ERK) and c-Jun N-Terminal Kinase (JNK) during 
hypoxia in cerebral cortical nuclei ofnewborn piglets. Neuroscience. 123: 1 79-186. 
Nakabayashi 1., Sasaki A. (2004) Optimal phosphorylation step number of intracellular signal­
transduction pathway. Journal ofTheoretical Biology. 233:413-421. 
Bendetz-Nezer S., Seger R. (2007) Role ofNon-phosphorylated Activation Loop Residues in 
Detennining ERK2 Dephosphorylation, Activity, and Subcellular Localization. Journal of 
Biological Chemistry. 282:25114-25122. 
Delivoria-Papadopoulos M., Gom M., AshrafQ. M., Mishra O. P. (2007). ATP and cytochrome 
c-dependent activation of caspase-9 during hypoxia in the cerebral cortex of newborn piglets. 
Neuroscience Letters. 429:115-119. 
Rahman Md. S., Thomas P. (2007). Molecular cloning, characterization and expression of two 
hypoxia-inducible factor alpha subunits, HIF-ln and HIF-2n, in a hypoxia-tolerant marine 
teleost, Atlantic croaker (Micropogonias undulatus). Gene. 396:273-282. 
Ramos W. J. (2008).The regulation of extracellular signal-regulated kinase 
(ERK) in mammalian cells. The International Journal ofBiochemiStry & Cell Biology. 40:2707­
2719. 
3S 

Selvendiran K., Bratasz A., Kuppusamy M. L., Tazi M. F., Rivera B. K., and Kuppusamy P. 
(2009). Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal 
transducer and activator of transcription 3. Int J Cancer. 125(9):2198-2204. 
Semenza. G. L. (2004). Hydroxlyation ofHIF-l: Oxygen Sensing at the Molecular Level. 
Physiology. 19: 176-182. 
Seo G. S., Lee S. H., Choi S. C., Choi E. Y., Oh H. M., Choi E. 1., Park D. S., Kim S. W., Kim 
T. H., Nab Y. H., Kim S., Kim S. H., You S. H., Jun C. D. (2006). Iron che1ator induces THP-l 
cell differentiation potentially by modulating intracellular glutathione levels. Free Radical 
Biology & Medicine. 40:1502-1512. 
Smensen B. S., Horsman M. R, Vorwn H., Honore B., Overgaard J., Alsner J. (2009). Proteins 
upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by 
proteomics. Radiotherapy and Oncology. 92:443-449. 
Takeda K., Akira S. (2000). STAT family of transcription factors in cytokine-mediated 
biological responses. Cytokine & Growth Factor Reviews. 11: 199-207. 
Tanga M., Cuia M., Donga Q., Rena H. M., Xiaoa B. G., Luob B. Y., Shaoa Y., Liua L., Zhoua 
H. G. (2009). The bradykinin B2 receptor mediates hypoxialreoxygenation induced neuronal cell 
apoptosis through the ERK1I2 pathway. Neuroscience Letters. 450:40:-44. 
Vacotto M., Coso 0., Fiszer de Plazas S. (2008). Programmed cell death and differential JNK, 
p38 and ERK response in a prenatal acute hypoxic hypoxia model. NeurochemiStry 
International. 52:857-863. 
Wagner B. A., Venkataraman S., Buettner G. R (2011). The rate of oxygen utilization by cells. 
Free Radical Biology and Medicine. 51(3):700-712. 
Wang G. S., Qian G. S., Zhou D. S., Zhao J. Q. (2005). JAK-STAT signaling pathway in 
pulmonary arterial smooth muscle cells is activated by hypoxia. Cell Biology International. 
29:598-603. 
Wang K., Jiang Y. Z., Chen D. B., Zheng 1. (2009). Hypoxia Enhances FGF2- and VEGF­
Stimulated Human Placental Artery Endothelial Cell Proliferation: Roles ofMEK1I2IERK112 
and PI3KJAKTI Pathways. Placenta. 30:1045-1051. 
Weston C. R, Davis R J. (2002) The JNK signal transduction pathway. Current Opinion in 
Genetics & Development. 12:14-21. 
Won S.1., Kim D.Y., and Gwag B.J. (2002). Cellular and molecular pathways of ischemic 
neuronal death. Journal o/Biochemistry and Molecular Biology. 35(1):67-86. 
36 
Wortzel I., Seger R. (2011). The ERK Cascade: Distinct Functions within Various Subcellular 
Organelles. Genes & Cancer. 2: 195-209 
Yang S. R., Cho S. D., Ahna N. S., Jung J. W., Park J. S., Jo E. H., Jae-Woong Hwang, Kim S. 
H., Lee B. H., Kanga K. S., Lee Y. S. (2005). The role ofp38 MAP kinase and c-Jun N-terminal 
protein kinase signaling in the differentiation and apoptosis of immortalized neural stem cells. 
Mutation Research. 579:47-57. 
Yuan Y., Hilliard G., Ferguson T., and Millhom D. E. (2003). Cobalt Inhibits the Interaction 
between Hypoxia-inducible Factor-alpha and von Hippel-Lindau Protein by Direct Binding to 
Hypoxia-inducible Factor-alpha. The Journal o/Biological Chemistry. 278(18): 15911-15916. 
Zarubin T., Han J. (2005). Activation and signaling ofthe p38 MAP kinase pathway. Cell 
Research. 15(1):11-18. 
37 

